Navigation Links
Mylan Launches Generic Version of Lipitor®
Date:5/29/2012

PITTSBURGH, May 29, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Laboratories Limited (formerly Matrix Laboratories Limited) has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Atorvastatin Calcium Tablets, 10 mg, 20 mg, 40 mg and 80 mg. Atorvastatin Calcium is the generic version of Pfizer's Lipitor® Tablets, which are indicated as an adjunct to diet in patients with primary hypercholesterolemia and mixed dyslipidemia to reduce elevated total cholesterol, LDL, triglycerides and to increase HDL cholesterol.

Mylan CEO Heather Bresch said: "We are very pleased to have received final approval for our ANDA for generic Lipitor®, the most widely prescribed drug in U.S. history. Through Mylan's launch of Atrovastatin Calcium Tablets, we look forward to be able to offer our customers, the American consumer and the U.S. government significant savings and expanded access to this important product."

Lipitor had U.S. sales of $8.1 billion for the twelve months ending March 31, 2012, according to IMS Health. Mylan is shipping this product immediately.

Currently, Mylan has 171 ANDAs pending FDA approval representing $84 billion in annual sales, according to IMS Health. Thirty-eight of these pending ANDAs are potential first-to-file opportunities, representing $25.5 billion in annual brand sales, for the 12 months ending Dec. 31, 2011, according to IMS Health.

Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service a habit, do what's right, not what's easy and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,100 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately one-third of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 150 countries and territories. Our workforce of more than 18,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world. But don't take our word for it. See for yourself. See inside. mylan.com 


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)
2. Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment Sinemet(R)
3. Mylan Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast
4. Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
5. Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)
6. Mylan Receives Approval for Generic Version of GoLytely(R)
7. Mylan Declares Quarterly Preferred Stock Dividend
8. Mylan Pre-Pays All Scheduled 2011 Term-Loan Borrowings
9. Mylan Confirms First-to-File Patent Challenge Relating to Vytorin(R) Cholesterol Medication
10. Mylans President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
11. Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories New Drug Application (NDA) for Efavirenz Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2020)... ... May 21, 2020 , ... The COVID-19 outbreak has changed the world we ... at SPIRE Institute & Academy (IA) have closely followed the recommendations of the Centers ... to prevent the spread of coronavirus, and keep students, campers, parents, guests and SPIRE ...
(Date:5/21/2020)... PENNSAUKEN, N.J (PRWEB) , ... May 21, 2020 ... ... fully integrated aluminum services resource, donated its second COVID-19 drive-through testing shelter in ... partnership with the Camden County Freeholders and Connor Strong & Buckelew and is ...
(Date:5/21/2020)... ... 21, 2020 , ... Sindledecker Dentistry of Boca ... closed due to the coronavirus pandemic and the practice was following state regulations ... remained open only for emergency needs and the staff, led by Dr. Amanda ...
Breaking Medicine Technology:
(Date:5/21/2020)... ... ... A new report from Kalorama Information, a market research publisher owned ... of care test industry. Given the need to diagnose patients quickly and the ... than in the past, according to the market researcher. , Diagnostic tests ...
(Date:5/16/2020)... ... ... who have gone to see Andy Gaertner, D.M.D , in the past, they will ... being allowed to re-open during the current pandemic, they have put some new protocols in ... as possible while going through their dental exams and treatments. , The new protocols that ...
(Date:5/16/2020)... HOWELL, Mich. (PRWEB) , ... May 16, 2020 , ... ... be caught relatively early, this will prevent permanent arthritis from developing. This can keep ... , Dr. Biernacki further states “It is estimated that the people who develop flat ...
(Date:5/15/2020)... (PRWEB) , ... May 15, 2020 , ... ... risk management solutions, recently announced the company and its healthcare-focused background screening division, ... Top 10 Pre-Employment Screening Consulting/Services Companies 2020. A distinguished panel comprising of CEOs, ...
(Date:5/15/2020)... Fla. (PRWEB) , ... May 15, 2020 , ... ... Tampa Bay, placed the final beam atop the hospital’s new six-story, 300,000 square ... Ave. and Bruce B. Downs Boulevard. The topping off celebrates the structural completion ...
Breaking Medicine News(10 mins):